Introduction: In the present study we investigated the performance, precision, and recovery of three different automated methods in determining cancer antigen (CA) 15-3 levels.Methods: Serum samples were obtained from 60 hospitalized female patients. As controls, commercially available samples were used. Cancer antigen (CA) 15-3 levels were measured using ARCHITECT CA 15-3, Elecsys® CA 15-3, and Vitros CA 15-3 immunoassays. A comparison of the results between the three methods was conducted, and the precision and recovery were analyzed.Results: Coefficient of variations (CVs), determined with low- and high-level-CA 15-3 control samples, and reproducibility values were: 2.56-2.80% and 3.10-4. 20% for ARCHITECT i2000SR immunoassay analyzer; 3.50-5.55% and 4.88-6.47% for Cobas E 601 analyzer; 3.30-4.0% and 4.30-4.80% for VITROS 5600 Integrated System, respectively. The percent recoveries were 95-98% for Elecsys® CA 15-3 assay, 93-105% for Vitros CA 15-3 assay, and 92-95% for ARCHITECT CA 15-3 assay. Method comparison results demonstrated correlation coefficient (r) in range from 0.994 to 1. The average CA 15-3 concentrations measured by Vitros, ARCHITECT, and Elecsys® were 157.24 +/- 329.75 U/mL, 100.91 +/-213.75 U/mL, and 80.93 +/- 173.29 U/mL, respectively.Conclusions: Tumor marker CA 15-3 in individual patients should be monitored using the same immunoassay method, reagents, and analyzer. Different immunoassays tested on different analyzers, often show large discrepancies in reported values for individual patients. Different immunoassay technologies quantify analytes of clinical interest using monoclonal or polyclonal antibodies. Thus, the usage of antibodies with different specificities could explain the differences in CA 15-3 serum values between different methods.

Introduction: Accommodative Convergence/Accommodation (AC/A) ratio is constant at one and the same person in the course of life, i.e. the same ratio accommodative convergence monitor any change in accommodation measured in diopters. Such a perfect relationship is possible if there are no refractive anomalies in both eyes and oculomotor imbalance of eye muscles. Material and methods: We are examined 50 patients with close brain injury, and patients which had problems with near vision, accommodation and convergency were reducted, with loss motor fussion, and preserved stereoscopis vision, and showed us, that disturbances are clear motor and folowed with incapable of patient to hold of superposition view to watching object. Results: The difference in average proximity distance vision and reading time with no fatigue after 6 months a statistically significant, the value of t-test, t = 1873 for p <0.01, r = 0. 718. The value of convergent fusion 6 months after treatment in 30% of the patients was from 0 to16 Pd, S. D. = 18. 6, and χ2 = 7. 22. In 18% of the patients was from 0 to 10 Pd, S. D = 17. 61, and χ2 = 5. 41, at 20% of patients 0 to 22 Pd, SD = 14. 18, χ2 = 6. 84, in 16% of patients 0 to 4 Pd, SD = 16. 41, χ2 t-test = 5. 13 and the remaining 16% of patients the value of convergent fusion is about 1 PD, S. D = 15. 01, χ2 t = 5. 18. All patients showed significant improvement in near vision compared to the value of convergent fusion before treatment where χ2 t-test = 9.41, after 6 months of treatment, there is considerable significance p < 0 01, t–test 0. 914, correlation coefficient r = 0. 881. Conclusion: Disturbances of AC / A ratio should be evaluated only with regard to all symptoms and is only possible by proper rating interference in reading.

Introduction: Traumatic injuries of the eye are the most common cause of loss of visual function. In our study we performed Ocula Trauma Score (OTS). We compared with the values of visual acuity of injury and thus get an accurate model for determining the prognostic value of the final visual acuity before treatment of the patient. This model is a reliable test for both the ophthalmologist and the patient. Aim of study: The aim of this study was to show the socioepidemiological and demographic profile, as well as the most common mechanism in ophthalmic injuries, so to determine the final visual acuity and assessment and evaluation of sensitivity and specificity of ocular trauma score (OTS), and most importantly to determine the prognostic value final visual acuity after eye injuries. Material and Method: We conducted a clinical-epidemiological, retrospective-prospective study at the Department of Ophthalmology, Clinical Centre University in Sarajevo in the period 2009-2011. A sample of 124 patients with diagnosed closed of eye injuries were recruited. We applied Classifying Closed Globe Injury, performed Calculating the OTS and convert of total raw points into % chance of vision outcomes. Results: Comparison of age groups by gender shows that there is no statistically significant (x2 = 5.155; p = 0.2718). Of the total number of closed eye injuries (N = 124) at the admission from groups D and E with the worst vision were 29 patients (23.38%), in group C had low visual acuity of 20 (16.12%), in group B the mean visual acuity 33 (26.61%), and in group A well-preserved visual acuity 42 (33.87%) patients. On the demission patients with well-preserved visual function was 84 (67.74%), with a medium of visual function 10 (80.64%), while the poorer visual function was 4 (3.225%) and 7 (5.645%) patients had a sense of light and projections and 1 (0.8%) patient had lost visual acuity-amaurosis. 18 (14:51%) patients did not take their eyesight due to a fresh post-operative recovery. Conclusion: Data on each patient are based on the possibility of such characteristics of the mechanism of injuries presentation of vision at the beginning of disease, injury and zones relative afferent pupillary defect possibility assumptions what will be with the vision postoperatively.

Introduction: The role of hyperhomocysteinemia in psychotic disorder can be explained by partial antagonism of homocysteine on NMDA-glycine receptor. Plasma concentration of homocysteine is an indicator of the status of the B-vitamins (folate, B12, B6). Folate defi ciency may have different effects on the neurochemical processes of schizophrenia. This suggests that the association between elevated levels of homocysteine and schizophrenia is biologically very likely. Methods: The study was consisted of 20 patients with schizophrenia and 20 healthy controls. We investigated the levels of serum homocysteine concentration using AxSYM (Abbott), levels of folate assay is two-step immunoassay to determine the presence folate in human serum using CMIA (chemiluminescent microparticle immunoassay) technology and Axsym Holo Tc is microparticle enzyme immunoassay (MEIA) for the quantitative determination of human holo TC in serum and determination defi cit of vitamin B 12. Results: The patients group has higher levels of homocysteine in compare with controls group for 3.85 μmol/L while the concentration of folate in the group of patients was lower for 9.17 ng/mL. The mean level of vitamin B-12 in investigation groups were in reference range 19.1-119 pmol/L, but patient group have lower average concentration of vitamin B-12 lower for 24.81 pmol/L compared to the control group. Conclusion: Our results showed that homocysteine concentration is inversely proportionate to folate concentration, i.e. as homocysteine concentration in serum increases, folate concentration falls. Shizophrenic patients with elevated tHcy level and low folate levels should have vitamin supplementation with folic acid.